Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32990
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Scheldeman, Lauranne | - |
dc.contributor.author | Wouters, Anke | - |
dc.contributor.author | Bertels, Jeroen | - |
dc.contributor.author | Dupont, Patrick | - |
dc.contributor.author | Cheng, Bastian | - |
dc.contributor.author | Ebinger, Martin | - |
dc.contributor.author | Endres, Matthias | - |
dc.contributor.author | Fiebach, Jochen B | - |
dc.contributor.author | Gerloff, Christian | - |
dc.contributor.author | Muir, Keith W | - |
dc.contributor.author | Nighoghossian, Norbert | - |
dc.contributor.author | Pedraza, Salvador | - |
dc.contributor.author | Simonsen, Claus Z | - |
dc.contributor.author | Thijs, Vincent N | - |
dc.contributor.author | Thomalla, Götz | - |
dc.contributor.author | Lemmens, Robin | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-06-07T02:37:23Z | - |
dc.date.available | 2023-06-07T02:37:23Z | - |
dc.date.issued | 2023-06 | - |
dc.identifier.citation | Stroke 2023 | en_US |
dc.identifier.issn | 1524-4628 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32990 | - |
dc.description.abstract | Reversibility of the diffusion-weighted imaging (DWI) lesion means that not all of the DWI lesion represents permanently injured tissue. We investigated DWI reversibility and the association with thrombolysis, reperfusion and functional outcome in patients from the WAKE-UP trial (Efficacy and Safety of Magnetic Resonance Imaging-Based Thrombolysis in Wake-Up Stroke). In this retrospective analysis of WAKE-UP, a randomized controlled trial (RCT) between September 2012 and June 2017 in Belgium, Denmark, France, Germany, Spain and United Kingdom, a convolutional neural network segmented the DWI lesions (b=1000 s/mm2) at baseline and follow-up (24 hours). We calculated absolute and relative DWI reversibility in 2 ways: first, a volumetric (baseline volume-24-hour volume >0) and second, a voxel-based (part of baseline lesion not overlapping with 24-hour lesion) approach. We additionally defined relative voxel-based DWI-reversibility >50% to account for coregistration inaccuracies. We calculated the odds ratio for reversibility according to treatment arm. We analyzed the association of reversibility with excellent functional outcome (modified Rankin Scale score of 0-1), in a multivariable model. In 363 patients, the median DWI volume was 3 (1-10) mL at baseline and 6 (2-20) mL at follow-up. Volumetric DWI reversibility was present in 19% (69/363) with a median absolute reversible volume of 1 mL (0-2) or 28% (14-50) relatively. Voxel-based DWI reversibility was present in 358/363 (99%) with a median absolute volume of 1 mL (0-2), or 22% (9-38) relatively. In 18% of the patients (67/363), relative voxel-based DWI reversibility >50% was present. Volumetric DWI reversibility and relative voxel-based DWI reversibility >50% was more frequent in patients treated with alteplase versus placebo (OR, 1.86 [95% CI, 1.09-3.17] and OR, 2.03 [95% CI, 1.18-3.50], respectively). Relative voxel-based DWI reversibility >50% was associated with excellent functional outcome (OR, 2.30 [95% CI, 1.17-4.51]). Small absolute volumes of DWI reversibility were present in a large proportion of randomized patients in the WAKE-UP trial. Reversibility was more often present after thrombolysis. | en_US |
dc.language.iso | eng | - |
dc.subject | arm | en_US |
dc.subject | diagnosis | en_US |
dc.subject | ischemic stroke | en_US |
dc.subject | odds ratio | en_US |
dc.subject | reperfusion | en_US |
dc.title | Reversibility of Diffusion-Weighted Imaging Lesions in Patients With Ischemic Stroke in the WAKE-UP Trial. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Stroke | en_US |
dc.identifier.affiliation | Department of Neurology, University Hospitals Leuven, Belgium | en_US |
dc.identifier.affiliation | Department of Neurosciences, Experimental Neurology KU Leuven, University of Leuven | en_US |
dc.identifier.affiliation | Processing Speech and Images, Department of Electrial Engineering, University of Leuven, Belgium | en_US |
dc.identifier.affiliation | Department of Neurosciences, Laboratory for Cognitive Neurology KU Leuven, University of Leuven, Belgium | en_US |
dc.identifier.affiliation | Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, University Medical Center Hamburg-Eppendorf, Germany | en_US |
dc.identifier.affiliation | Center for Stroke Research Berlin Charit. - Universit.tsmedizin Berlin, Germany | en_US |
dc.identifier.affiliation | Klinik und Hochschulambulanz für Neurologie, Charit. - Universit.tsmedizin Berlin, Germany | en_US |
dc.identifier.affiliation | Neurology | en_US |
dc.identifier.affiliation | School of Psychology & Neuroscience, University of Glasgow, United Kingdom | en_US |
dc.identifier.affiliation | Department of Stroke Medicine, Universit. Claude Bernard Lyon 1, CREATIS CNRS UMR 5220-INSERM U1206, INSA- Lyon, Hospices Civils de Lyon, France | en_US |
dc.identifier.affiliation | Department of Radiology, Institut de Diagnostic per la Image Hospital Dr Josep Trueta, Institut d'Investigaci. Biomedica de Girona Parc Hospitalari Marti i Julia de Salt - Edifici M2, Girona, Spain | en_US |
dc.identifier.affiliation | Department of Neurology, Aarhus University Hospital, Denmark | en_US |
dc.identifier.affiliation | The Florey Institute of Neuroscience and Mental Health | en_US |
dc.identifier.affiliation | ExcellenceCluster NeuroCure | en_US |
dc.identifier.affiliation | Center for Brain and Disease Research, Laboratory of Neurobiology, VIB, Leuven, Belgium | en_US |
dc.identifier.affiliation | German Center for Neurodegenerative Diseases, partner site Berlin | en_US |
dc.identifier.affiliation | Department of Neurology, Amsterdam University Medical Centers, the Netherlands | en_US |
dc.identifier.affiliation | Leuven Brain Institute, Belgium | en_US |
dc.identifier.affiliation | Klinik für Neurologie, Medical Park Berlin Humboldtmühle, Germany | en_US |
dc.identifier.affiliation | German Center for Cardiovascular Research, partner site Berlin | en_US |
dc.identifier.doi | 10.1161/STROKEAHA.122.041505 | en_US |
dc.type.content | Text | en_US |
dc.identifier.orcid | 0000-0002-5263-3550 | en_US |
dc.identifier.orcid | 0000-0001-5229-2699 | en_US |
dc.identifier.orcid | 0000-0001-7206-2671 | en_US |
dc.identifier.orcid | 0000-0003-1980-2540 | en_US |
dc.identifier.orcid | 0000-0003-2434-1822 | en_US |
dc.identifier.orcid | 0000-0002-5073-4665 | en_US |
dc.identifier.orcid | 0000-0001-6520-3720 | en_US |
dc.identifier.orcid | 0000-0002-7936-6958 | en_US |
dc.identifier.orcid | 0000-0002-6484-8882 | en_US |
dc.identifier.orcid | 0000-0003-0594-4409 | en_US |
dc.identifier.orcid | 0000-0003-2517-4413 | en_US |
dc.identifier.orcid | 0000-0003-1363-0266 | en_US |
dc.identifier.orcid | 0000-0002-6614-8417 | en_US |
dc.identifier.orcid | 0000-0002-4785-1449 | en_US |
dc.identifier.orcid | 0000-0002-4948-5956 | en_US |
dc.identifier.pubmedid | 37158080 | - |
dc.description.volume | 54 | - |
dc.description.issue | 6 | - |
dc.description.startpage | 1560 | - |
dc.description.endpage | 1568 | - |
dc.subject.meshtermssecondary | Stroke/diagnostic imaging | - |
dc.subject.meshtermssecondary | Stroke/drug therapy | - |
dc.subject.meshtermssecondary | Stroke/pathology | - |
dc.subject.meshtermssecondary | Diffusion Magnetic Resonance Imaging/methods | - |
dc.subject.meshtermssecondary | Tissue Plasminogen Activator/therapeutic use | - |
dc.subject.meshtermssecondary | Ischemic Stroke/drug therapy | - |
local.name.researcher | Thijs, Vincent N | |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | Journal Article | - |
crisitem.author.dept | Neurology | - |
crisitem.author.dept | The Florey Institute of Neuroscience and Mental Health | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.